Comparison of Neurone-specific Enolase and Pro-gastrin Releasing Peptide in the Prognostic Evaluation of Small Cell Lung Cancer Patients

Clinical Oncology

Volumn 18, Issue 9, 2006, Pages 720-

  Satoh, H ^a   Kagohashi, K ^a   Kurishima, K ^a   Ishikawa, H ^a   Ohtsuka, M ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NEURON SPECIFIC ENOLASE; PROGASTRIN RELEASING PEPTIDE; TUMOR MARKER;

CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; IMMUNOASSAY; LETTER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; STATISTICAL SIGNIFICANCE; SURVIVAL TIME;

CARCINOMA, SMALL CELL; HUMANS; LUNG NEOPLASMS; PEPTIDE FRAGMENTS; PEPTIDES; PHOSPHOPYRUVATE HYDRATASE; PROGNOSIS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33749061059     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2006.07.009     Document Type: Letter

References (5)

1. Bonner J.A., Sloan J.A., Rowland Jr. K.M., et al. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer. Clin Cancer Res 6 (2000) 597-601
2. Satoh H., Ishikawa H., Kurishima K., Yamashita Y.T., Ohtsuka M., and Sekizawa K. Cut-off levels of NSE to differentiate SCLC from NSCLC. Oncol Rep 9 (2002) 581-583
3. Pujol J.L., Quantin X., Jacot W., Boher J.M., Grenier J., and Lamy P.J. Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer. Lung Cancer 39 (2003) 131-138
4. Niho S., Nishiwaki Y., Goto K., et al. Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen. Lung Cancer 27 (2000) 159-167
5. Shibayama T., Ueoka H., Nishii K., et al. Complementary roles of pro-gastrin releasing peptide(proGRP) and neuron specific enolase(NSE) in diagnosis and prognosis of small-cell lung cancer(SCLC). Lung Cancer 32 (2001) 61-69